Patents by Inventor Joost Louwagie

Joost Louwagie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunodiagnostic assays using reducing agents
    Patent number: 7935490
    Abstract: The present invention relates to a solid phase immunoassay comprising on said solid phase an antigen in the presence of a reducing agent.
    Type: Grant
    Filed: August 2, 2006
    Date of Patent: May 3, 2011
    Assignee: N.V. Innogenetics
    Inventors: Geert Maertens, Joost Louwagie, Alfons Bosman, Erwin Sablon, Maan Zrein
  • Methods for Detecting Epigenetic Modifications
    Publication number: 20100144836
    Abstract: A method of detecting a predisposition to, or the incidence of, cancer in a sample comprises detecting an epigenetic change in at least one gene selected from an NDRG4/NDRG2 subfamily gene, GATA4, OSMR, GATA5, SFRP1, ADAM23, JPH3, SFRP2, APC, MGMT, 11112, BNIP3, FOXE1, SYNE1, S0X17, PHACTR3 and JAM3, wherein detection of the epigenetic change is indicative of a predisposition to, or the incidence of, cancer. Also described are pharmacogenetic methods for determining suitable treatment regimens for cancer and methods for treating cancer patients, based around selection of the patients according to the methods of the invention. The present invention is also concerned with improved methods of collecting, processing and analyzing samples, in particular body fluid samples. These methods may be useful in diagnosing, staging or otherwise characterizing various diseases.
    Type: Application
    Filed: January 9, 2008
    Publication date: June 10, 2010
    Applicant: ONCOMETHYLOME SCIENCES SA
    Inventors: Manon Van Engeland, Manon Adriaan De Bruine, Arjan Griffioen, Joost Louwagie, Katja Bierau, Gontran Brichard, Gaëtan Otto, Maarten Penning
  • Immunodiagnostic assays using reducing agents
    Publication number: 20060263854
    Abstract: The present invention relates to a solid phase immunoassay comprising on said solid phase an antigen in the presence of a reducing agent.
    Type: Application
    Filed: August 2, 2006
    Publication date: November 23, 2006
    Applicant: N.V. INNOGENETICS
    Inventors: Geert Maertens, Joost Louwagie, Alfons Bosman, Erwin Sablon, Maan Zrein
  • Method for detection of drug-induced mutations in the reverse transcriptase gene
    Patent number: 6713251
    Abstract: The present invention relates to a method for the rapid and reliable detection of drug-induced mutations in the reverse transcriptase gene allowing the simultaneous characterization of a range of codons involved in drug resistance using specific sets of probes optimized to function together in a reverse-hybridization assay.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: March 30, 2004
    Assignee: Innogenetics N.V.
    Inventors: Lieven Stuyver, Joost Louwagie, Rudi Rossau
  • Method for detection of drug-induced mutations in the reverse transcriptase gene
    Publication number: 20030077575
    Abstract: The present invention relates to a method for the rapid and reliable detection of drug-induced mutations in the reverse transcriptase gene allowing the simultaneous characterization of a range of codons involved in drug resistance using specific sets of probes optimized to function together in a reverse-hybridization assay.
    Type: Application
    Filed: August 31, 2001
    Publication date: April 24, 2003
    Applicant: INNOGENETICS N.V.
    Inventors: Lieven Stuyver, Joost Louwagie, Rudi Rossau